Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors
Clinical trial NCT03221166 · TERMINATED
Trial details
- NCT number
- NCT03221166
- Sponsor
- IRCCS Burlo Garofolo
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-27
- Primary completion
- 2020-07-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.